CN101879250B - 关节止痛凝胶膏剂及制备方法 - Google Patents
关节止痛凝胶膏剂及制备方法 Download PDFInfo
- Publication number
- CN101879250B CN101879250B CN201010209634XA CN201010209634A CN101879250B CN 101879250 B CN101879250 B CN 101879250B CN 201010209634X A CN201010209634X A CN 201010209634XA CN 201010209634 A CN201010209634 A CN 201010209634A CN 101879250 B CN101879250 B CN 101879250B
- Authority
- CN
- China
- Prior art keywords
- parts
- component
- add
- purified water
- gel paste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000006820 Arthralgia Diseases 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 60
- 239000000499 gel Substances 0.000 claims abstract description 31
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000008213 purified water Substances 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 16
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 14
- 108010010803 Gelatin Proteins 0.000 claims abstract description 14
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims abstract description 14
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 14
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims abstract description 14
- 229910021502 aluminium hydroxide Inorganic materials 0.000 claims abstract description 14
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 14
- 239000008273 gelatin Substances 0.000 claims abstract description 14
- 229920000159 gelatin Polymers 0.000 claims abstract description 14
- 235000019322 gelatine Nutrition 0.000 claims abstract description 14
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 14
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims abstract description 14
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 14
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 14
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 14
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims abstract description 14
- 235000002906 tartaric acid Nutrition 0.000 claims abstract description 14
- 239000011975 tartaric acid Substances 0.000 claims abstract description 14
- 229960001047 methyl salicylate Drugs 0.000 claims abstract description 13
- 229920000136 polysorbate Polymers 0.000 claims abstract description 6
- 229950008882 polysorbate Drugs 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 18
- 239000012530 fluid Substances 0.000 claims description 13
- 239000000084 colloidal system Substances 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 10
- 238000013019 agitation Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 235000012239 silicon dioxide Nutrition 0.000 claims description 8
- 238000010792 warming Methods 0.000 claims description 5
- 239000004745 nonwoven fabric Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 150000003840 hydrochlorides Chemical class 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 19
- 235000011187 glycerol Nutrition 0.000 abstract description 18
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 6
- 239000003960 organic solvent Substances 0.000 abstract description 5
- 230000035699 permeability Effects 0.000 abstract description 4
- 230000000638 stimulation Effects 0.000 abstract description 4
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 238000011068 loading method Methods 0.000 abstract description 3
- 230000014759 maintenance of location Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract 2
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 abstract 1
- 241001106067 Atropa Species 0.000 abstract 1
- 240000004160 Capsicum annuum Species 0.000 abstract 1
- 241000723346 Cinnamomum camphora Species 0.000 abstract 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 229960000846 camphor Drugs 0.000 abstract 1
- 229930008380 camphor Natural products 0.000 abstract 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 abstract 1
- 229940124274 edetate disodium Drugs 0.000 abstract 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 abstract 1
- 235000019477 peppermint oil Nutrition 0.000 abstract 1
- 229960001367 tartaric acid Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- 229940025250 camphora Drugs 0.000 description 9
- 239000010238 camphora Substances 0.000 description 9
- 229920001214 Polysorbate 60 Polymers 0.000 description 8
- 239000013521 mastic Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 6
- 239000002674 ointment Substances 0.000 description 6
- 239000011505 plaster Substances 0.000 description 5
- -1 Oleum menthae Substances 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000035800 maturation Effects 0.000 description 4
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 4
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 4
- 229940113124 polysorbate 60 Drugs 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001741 anti-phlogistic effect Effects 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 230000008338 local blood flow Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
时间 | 3hr | 4hr | 5hr | 6hr |
对照组 | 78.8 | 92.8 | 96.8 | 92.8 |
关节止痛凝胶膏剂 | 67.5 | 73.8 | 77 | 73.6 |
时间 | 3hr | 4hr | 5hr | 6hr |
改善率 | 14.34% | 20.47% | 20.45% | 20.69% |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010209634XA CN101879250B (zh) | 2010-06-25 | 2010-06-25 | 关节止痛凝胶膏剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010209634XA CN101879250B (zh) | 2010-06-25 | 2010-06-25 | 关节止痛凝胶膏剂及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101879250A CN101879250A (zh) | 2010-11-10 |
CN101879250B true CN101879250B (zh) | 2012-10-31 |
Family
ID=43051479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010209634XA Active CN101879250B (zh) | 2010-06-25 | 2010-06-25 | 关节止痛凝胶膏剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101879250B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102406840B (zh) * | 2011-11-18 | 2015-01-21 | 云南省药物研究所 | 一种肿痛凝胶膏剂及其制备方法 |
CN104013729A (zh) * | 2014-06-20 | 2014-09-03 | 安徽安科余良卿药业有限公司 | 关节止痛凝胶及其制备方法 |
CN107296951A (zh) * | 2017-07-28 | 2017-10-27 | 四川利佰生物科技有限公司 | 风湿冷敷贴及其制备方法 |
CN107296852A (zh) * | 2017-07-28 | 2017-10-27 | 四川利佰生物科技有限公司 | 骨质增生冷敷贴及其制备方法 |
CN107375527A (zh) * | 2017-07-28 | 2017-11-24 | 四川利佰生物科技有限公司 | 跌打冷敷贴及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1613463A (zh) * | 2003-11-07 | 2005-05-11 | 北京东方凯恩医药科技有限公司 | 一种外用治疗关节疼痛的中药组合物贴膏 |
CN1679520A (zh) * | 2005-01-11 | 2005-10-12 | 中国人民解放军第二军医大学 | 一种复方镇痛巴布剂 |
-
2010
- 2010-06-25 CN CN201010209634XA patent/CN101879250B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1613463A (zh) * | 2003-11-07 | 2005-05-11 | 北京东方凯恩医药科技有限公司 | 一种外用治疗关节疼痛的中药组合物贴膏 |
CN1679520A (zh) * | 2005-01-11 | 2005-10-12 | 中国人民解放军第二军医大学 | 一种复方镇痛巴布剂 |
Non-Patent Citations (1)
Title |
---|
赵斌等.中药巴布剂亲水性基质的研究进展.《中华中医药学刊》.2008,第26卷(第6期),1276-1277. * |
Also Published As
Publication number | Publication date |
---|---|
CN101879250A (zh) | 2010-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105769654B (zh) | 一种舒敏护肤组合物及其在化妆品中的应用 | |
CN101879250B (zh) | 关节止痛凝胶膏剂及制备方法 | |
CN102309750B (zh) | 一种专用于女性私处的调理养生膜 | |
CN107375032A (zh) | 一种修复皮肤屏障的组合物及制备方法 | |
CN1332686C (zh) | 一种治疗跌打损伤的中药及其贴膏的制备工艺 | |
CN107412255A (zh) | 皮肤屏障修复组合物及制剂 | |
CN104224979A (zh) | 穴位贴敷治疗肺气肿的中药巴布剂及其制备方法 | |
CN101919941B (zh) | 用于肾功能治疗与保健的外用中药组合物及其在制备肾功能治疗与保健中药巴布剂中的应用 | |
CN105663468A (zh) | 一种具有缓解视疲劳及眼周护理双重功效的双亲凝胶眼贴及其制备方法 | |
CN105126037B (zh) | 一种含天然成分提取物的跌打损伤药膏及其制备方法 | |
CN1274342C (zh) | 治疗痛风的中药外用制剂及其制备方法 | |
CN105796925A (zh) | 一种纯中药眼贴 | |
CN114848294A (zh) | 一种痛经贴及其制备工艺 | |
CN102274359B (zh) | 标本兼治型白癜风遮盖液及制备方法 | |
CN104825648A (zh) | 一种消炎镇痛膏及其制备方法 | |
CN102423364A (zh) | 一种治疗面瘫的牵正膏药及其制备方法 | |
CN107375012A (zh) | 一种皮肤屏障修复组合物及制剂 | |
CN106728934A (zh) | 一种以高分子材料为载体制备的外用贴剂及其制备方法 | |
CN103316260B (zh) | 用于治疗手足癣的按摩膏 | |
DE102010056029A1 (de) | Wärmekompresse und deren Verwendung | |
CN109395050A (zh) | 治疗腹泻的儿科外用按摩软膏配方、制备方法和应用 | |
CN104997981A (zh) | 一种治疗局部风湿性疼痛综合症的中药凝胶膏及其制备方法 | |
CN103536776B (zh) | 中药液体膏药及制备方法 | |
CN108542847A (zh) | 一种祛除痘、疖及去痘印的组合物及其应用 | |
CN108451991A (zh) | 一种牛皮癣配方及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HEXIN MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD. Free format text: FORMER OWNER: ANSSURE (TIANJIN) PHARMACEUTICAL CO., LTD. Effective date: 20130916 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300461 TANGGU, TIANJIN TO: 201203 PUDONG NEW AREA, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130916 Address after: 201203 Shanghai city Pudong New Area Zhangjiang Dahl Road 88 building 6 Room 405 Patentee after: HEXIN MEDICAL TECHNOLOGY (SHANGHAI) Co.,Ltd. Address before: 300461 No. ten, No. 129, Haibin Road, Tianjin Free Trade Zone, Tianjin, 2-B401 Patentee before: Anssure (Tianjin) Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210511 Address after: 261000 Room 201, area h, 39 Fenghuang street, Fangzi District, Weifang City, Shandong Province Patentee after: Hexinotai Pharmaceutical Technology (Shandong) Co.,Ltd. Address before: 201203 Room 405, building 6, No.88, daerwen Road, Zhangjiang, Pudong New Area, Shanghai Patentee before: HEXIN MEDICAL TECHNOLOGY (SHANGHAI) Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20221121 Address after: 150000 Yilan town Tonghe community, Yilan County, Harbin City, Heilongjiang Province Patentee after: Harbin hexinotai Pharmaceutical Co.,Ltd. Address before: 261000 Room 201, area h, 39 Fenghuang street, Fangzi District, Weifang City, Shandong Province Patentee before: Hexinotai Pharmaceutical Technology (Shandong) Co.,Ltd. |
|
TR01 | Transfer of patent right |